Life saving overdose-reversing drug still not being accessed

Despite now being available over the counter, take-home naloxone programs designed to be used by potential overdose witnesses to prevent opioid-related harms, are not being bought in increased numbers, according to the authors of research published online today by the Medical Journal of Australia.

Continue reading

ACMD public evidence gathering: request for written evidence

Forms for members of the public to provide written evidence on young people’s drug use and naloxone provision.

Following advice in response to COVID-19, 3 public evidence gathering days which were being arranged by the ACMD to inform reports on young people’s drug use and naloxone provision have been postponed until further notice. We are instead inviting relevant stakeholders to provide written submissions to help support these workstreams.

Continue reading

A Crucial Conversation

Many of us have had to address the concerns of those who feared that the supply of Take Home Naloxone would increase risk taking behaviours among opiate users, but today we’re able to point to a continually increasing global evidence base that naloxone saves lives. (Links to a PDF of DDN magazine, naloxone article on p16).

Continue reading

This website has been made possible through the provision of an arm length/unrestricted educational grant from Ethypharm. Ethypharm do not control and are not liable for any of the content placed, or any of the claims that may be made, on this site.

HIT